Arterial Hypertension as a Risk Comorbidity Associated with COVID-19 Pathology
Coronavirus disease 2019 (COVID-19), caused by the novel coronavirus severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2), is an ongoing global public health challenge. Current clinical data suggest that, in COVID-19 patients, arterial hypertension (AH) is one of the most common cardiovascul...
Saved in:
| Main Authors: | Alexander Kamyshnyi, Inna Krynytska, Victoriya Matskevych, Mariya Marushchak, Oleh Lushchak |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2020-01-01
|
| Series: | International Journal of Hypertension |
| Online Access: | http://dx.doi.org/10.1155/2020/8019360 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Prenatal Malnutrition-Induced Epigenetic Dysregulation as a Risk Factor for Type 2 Diabetes
by: Alexander Vaiserman, et al.
Published: (2019-01-01) -
COVID 19 and the Related Risk with the Apearance of Arterial Hypertension
by: Freddy Fernando Jumbo Salazar, et al.
Published: (2022-12-01) -
FEATURES OF THERAPY OF ELDERLY PATIENTS WITH COMORBID PATHOLOGY – ARTERIAL HYPERTENSION WITH CONCOMITANT CHRONIC OBSTRUCTIVE PULMONARY DISEASE
by: T.V. Nastroga
Published: (2017-11-01) -
Modern fixed combinations of antihypertensive drugs in the treatment of arterial hypertension and obesity: can this comorbid pathology be effectively controlled?
by: Yu. A. Vasyuk, et al.
Published: (2019-09-01) -
New approaches to the treatment of patients with arterial hypertension with comorbid pathology living in the environmental conditions of the south of Western Siberia
by: Yu. A. Nikolaev, et al.
Published: (2021-10-01)